Glioblastoma trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Targeted Pediatric High-Grade Glioma Therapy

  Where

  Auckland

  Age

  12 months to 39 years

  People

  350 worldwide

  Run by

  Nationwide Children's Hospital

  See details and how to joinNCT05839379
• Phase 2Taking people
  Study of Olutasidenib and Temozolomide in HGG

  Where

  Auckland

  Age

  12 years to 39 years

  People

  60 worldwide

  Run by

  Rigel Pharmaceuticals

  See details and how to joinNCT06161974
• Early phase 1Taking people
  Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  Where

  Auckland

  Age

  1 year to 21 years

  People

  15 worldwide

  Run by

  Nationwide Children's Hospital

  See details and how to joinNCT06333899
• Phase 2Taking people
  Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  Where

  Auckland

  Age

  12 months to 39 years

  People

  120 worldwide

  Run by

  Nationwide Children's Hospital

  See details and how to joinNCT05843253